News

Pneumonia Patients Admitted Late To ICU Have Higher Mortality


 

SAN FRANCISCO — Patients with community-acquired pneumonia who were admitted to the intensive care unit 2 or more days after diagnosis were more than twice as likely to die within 30 days as were those who were admitted in 24 hours or less, according to a poster presentation at the International Conference of the American Thoracic Society.

The retrospective, observational study involved 161 patients seen over a 3-year period at two tertiary care hospitals in San Antonio. All patients were 18 years old or older, all had received a chest x-ray within 24 hours of admission, and all had a diagnosis consistent with community-acquired pneumonia, wrote Dr. Marcos I. Restrepo and his colleagues at the University of Texas at San Antonio.

There were no significant differences in demographic or clinical characteristics between the 142 patients admitted to the ICU early and the 19 admitted late. There were also no significant differences between the two groups in whether they received antibiotics within 4 hours, whether their blood was cultured appropriately, or whether they received guideline-concordant antibiotic therapy.

After 30 days, 47% of the patients who had been admitted late had died, compared with 23% of the patients who had been admitted early, a significant difference.

The investigators wrote that further research is needed to isolate the factors underlying the association between late ICU admission and increased mortality.

Recommended Reading

Primary Care Often Omits Discussion of STD/HIV
MDedge Internal Medicine
Histology Shows Wide Variation in Resurgent Syphilis
MDedge Internal Medicine
Anti-MRSA Program Succeeds Across Institutions : 'A coordinated hand-hygiene program [can] bring significant reductions in MRSA infection rates.'
MDedge Internal Medicine
Data Watch: Steady Growth in Methicillin-Resistant Staphylococcus aureus Cases in U.S. Hospitals
MDedge Internal Medicine
New Community-Acquired MRSA Subclone Has Emerged
MDedge Internal Medicine
How to Field Patient Questions About Gardasil and Zostavax
MDedge Internal Medicine
Rocky Mountain Spotted Fever Cases on the Rise
MDedge Internal Medicine
Adjunctive Gabapentin May Help in Postherpetic Neuralgia
MDedge Internal Medicine
Tackling h VISA in the Era of MRSA Infections
MDedge Internal Medicine
Investigational 'Bird Flu' Vaccine Well Tolerated
MDedge Internal Medicine